The US silent heart attack market is estimated to grow modestly at a CAGR of around 6.4% during the forecast period. The US contributes significantly to the growth of the silent heart attack treatment market in North America. The US has a high incidence and prevalence rate of heart diseases due to a sedentary lifestyle, excessive consumption of alcohol, consumption of junk food, and a huge number of diabetic and obese patients. According to the Center for Disease Control and Prevention (CDC), every year, around 0.8 million Americans have a heart attack. In the US, every 40 seconds, someone has a heart attack and a 1 in 5 heart attack that occurs is silent. As per the Institute for Health Metrics and Evaluation, the incidence of CVD is increasing continuously in the country.

The US silent heart attack market is segmented into diagnosis, treatment, and end-user. Based on the diagnosis, the market is segmented into an electrocardiography (ECG), chest x-ray, computed tomography (CT Scan), echocardiography, and others (blood test). Based on treatment, the market is segmented into medication and surgery. Based on end-user, the market is segmented into hospitals & clinics and ambulatory surgical centers (ASCs). ECG is the most used technology to diagnose a silent heart attack. ECG provides insights about heart rate, indicates if there is an enlargement of the heart due to high blood pressure (hypertension) or evidence of a previous heart attack.

The companies which are contributing to the growth of the US silent heart attack market include Abbott Laboratories Inc., Johnson & Johnson Services Inc., Pfizer Inc., Bayer AG, and Novartis AG. The market players are considerably contributing to the market growth by the adoption of various strategies including new product launch, merger, and acquisition, collaborations with government, funding to the start-ups, and technological advancements to stay competitive in the market. 

Research Methodology

The market study of the US silent heart attack market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include

• Financial reports of companies involved in the market.
• Whitepapers, research-papers, and news blogs.
• Company websites and their product catalog.

The report provides an in-depth analysis of market size, various services offered by the players, and market opportunity. The report will serve as a source for 360-degree analysis of the market delivering insights for making better business decisions.

Market Segmentation

1. US Silent heart attack Market Research and Analysis by Diagnosis
2. US Silent heart attack Market Research and Analysis by Treatment
3. US Silent heart attack Market Research and Analysis by End-Users

The Report Covers

• Comprehensive research methodology of the US silent heart attack market.
• This report also includes a detailed and extensive market overview with key analyst insights.
• An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
• Analysis of regional regulations and other government policies impacting the US silent heart attack market.
• Insights about market determinants which are stimulating the US silent heart attack market.
• Detailed and extensive market segments with regional distribution of forecasted revenues.
• Extensive profiles and recent developments of market players.